FDA.reportPublic FDA data

Jesduvroq 6 MG Oral Tablet

RxCUI
2628233
RxNorm name
Jesduvroq 6 MG Oral Tablet
Display name
Jesduvroq 6 MG Oral Tablet
Full name
Jesduvroq 6 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JesduvroqDAPRODUSTATGlaxoSmithKline LLCd82aa06e-5a33-4844-99b7-4701313455a42023-08-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2628233

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d82aa06e-5a33-4844-99b7-4701313455a4Jesduvroq 6 MG Oral Tablet [PSN] · daprodustat 6 MG Oral Tablet [Jesduvroq] [SBD] · Jesduvroq 6 MG Oral Tablet [SY]35These highlights do not include all the information needed to use JESDUVROQ safely and effectively. See full prescribing information for JESDUVROQ. JESDUVROQ (daprodustat) tablets, for oral use Initial U.S. Approval: 202320230830